GILD vs QIPT · P/E 18, rev $7.80B vs rev $245.9M
Gilead Sciences Inc (GILD) versus Quipt Home Medical Corp (QIPT) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Quipt Home Medical Corp (QIPT) is a medical distribution company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported QIPT revenue for 2024-09-30 was $245.9M. Net income was -$6.8M. Revenue was up 16.2% from 2023-09-30 to 2024-09-30. QIPT currently screens at market cap $162.3M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. QIPT currently screens at market cap $162.3M.
Not investment advice. Open the GILD and QIPT stock pages for the full models.
Not investment advice.